These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12160588)

  • 21. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women.
    Hooton TM; Winter C; Tiu F; Stamm WE
    JAMA; 1995 Jan; 273(1):41-5. PubMed ID: 7654268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections.
    Walters DJ; Solomkin JS; Paladino JA
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):551-61. PubMed ID: 10662480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic bacterial prostatitis: therapeutic experience with ciprofloxacin.
    Weidner W; Schiefer HG
    Infection; 1991; 19 Suppl 3():S165-6. PubMed ID: 2055654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. The German Prostatitis Study Group.
    Naber KG; Busch W; Focht J
    Int J Antimicrob Agents; 2000 Mar; 14(2):143-9. PubMed ID: 10720805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.
    Goldie SJ; Yazdanpanah Y; Losina E; Weinstein MC; Anglaret X; Walensky RP; Hsu HE; Kimmel A; Holmes C; Kaplan JE; Freedberg KA
    N Engl J Med; 2006 Sep; 355(11):1141-53. PubMed ID: 16971720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic assessment of three antimicrobial therapies for uncomplicated urinary tract infection in women.
    Huang X; Hartzema AG; Raasch RH; Kauf TL; Norwood GJ
    Clin Ther; 1999 Sep; 21(9):1578-88. PubMed ID: 10509852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostatitis: review of pharmacokinetics and therapy.
    Meares EM
    Rev Infect Dis; 1982; 4(2):475-83. PubMed ID: 7051242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ciprofloxacin versus trimethoprim-sulfamethoxazole: treatment of community-acquired urinary tract infections in a prospective, controlled, double-blind comparison.
    Grubbs NC; Schultz HJ; Henry NK; Ilstrup DM; Muller SM; Wilson WR
    Mayo Clin Proc; 1992 Dec; 67(12):1163-8. PubMed ID: 1469927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis.
    Naber KG;
    Int J Antimicrob Agents; 2002 Jul; 20(1):18-27. PubMed ID: 12127707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cost-effectiveness of the treatment of acute and chronic rhinosinusitis at the IMSS].
    Muñoz-Carlin Mde L; Nevárez-Sida A; García-Contreras F; Mendieta-Sevilla SR; Constantino-Casas P
    Rev Invest Clin; 2007; 59(3):197-205. PubMed ID: 17910412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial prostatitis: treatment with trimethoprim-sulfamethoxazole.
    McGuire EJ; Lytton B
    Urology; 1976 May; 7(5):499-500. PubMed ID: 1274009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of bacterial prostatitis: what's new?
    Naber KG
    BJU Int; 2008 Mar; 101 Suppl 3():7-10. PubMed ID: 18307679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study.
    Weidner W; Schiefer HG; Dalhoff A
    Am J Med; 1987 Apr; 82(4A):280-3. PubMed ID: 3555048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pH of the prostatic fluid in health and disease: implications of treatment in chronic bacterial prostatitis.
    Pfau A; Perlberg S; Shapira A
    J Urol; 1978 Mar; 119(3):384-7. PubMed ID: 25346
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of methicillin-resistant Staphylococcus aureus infection: a healthcare system perspective.
    von Dach E; Morel CM; Murthy A; Pagani L; Macedo-Vinas M; Olearo F; Harbarth S
    Clin Microbiol Infect; 2017 Sep; 23(9):659-666. PubMed ID: 28232163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacoeconomic evaluation of use of ciprofloxacin and norfloxacin with cost-benefit analysis].
    Skrbo A; Selava A; Zunić L
    Med Arh; 2003; 57(5-6):285-9. PubMed ID: 15022580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin.
    Schaeffer AJ; Darras FS
    J Urol; 1990 Sep; 144(3):690-3. PubMed ID: 2201796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year.
    Torrance G; Walker V; Grossman R; Mukherjee J; Vaughan D; La Forge J; Lampron N
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):499-520. PubMed ID: 10662396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ofloxacin in the management of complicated urinary tract infections, including prostatitis.
    Cox CE
    Am J Med; 1989 Dec; 87(6C):61S-68S. PubMed ID: 2690622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of management strategies for acute urethritis in the developing world.
    Crabbé F; Vuylsteke B; de Clerck M; Laga M
    Trop Med Int Health; 2000 Sep; 5(9):640-7. PubMed ID: 11044279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.